dc.contributor.author | Kose, H | |
dc.contributor.author | Cokneseli, B | |
dc.contributor.author | Koksoy, FN | |
dc.contributor.author | Yalcin, O | |
dc.contributor.author | Soybir, GR | |
dc.date.accessioned | 2021-03-03T18:22:10Z | |
dc.date.available | 2021-03-03T18:22:10Z | |
dc.date.issued | 1997 | |
dc.identifier.citation | Koksoy F., Kose H., Soybir G., Yalcin O., Cokneseli B., "The prophylactic effects of superoxide dismutase, catalase, desferrioxamine, verapamil and disulfiram in experimental colitis", JOURNAL OF THE ROYAL COLLEGE OF SURGEONS OF EDINBURGH, cilt.42, sa.1, ss.27-30, 1997 | |
dc.identifier.issn | 0035-8835 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_4ea6c2ac-5c38-4286-b2bc-134b0af52ef8 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/56166 | |
dc.description.abstract | In our study we have tried to compare the prophylactic effects of superoxide dismutase (SOD), SOD+catalase (CAT), desferrioxamine, verapamil and disulfiram, which are all free oxygen radical (FOR) scavengers, in an animal model of experimental acetic acid colitis. The control group had 58.3% colonic ulcers. The SOD group (48.6% ulcerated area) and the SOD+CAT group (47.2% ulcerated area) did not show a significant difference when compared with the control group. The values were significantly different in all other groups when compared with the control group (desferrioxamine (29.2% ulcerated area): P < 0.01;verapamil (10.4% ulcerated area) and disulfiram (7.6% ulcerated area): P < 0.001. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | CERRAHİ | |
dc.subject | Klinik Tıp | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.title | The prophylactic effects of superoxide dismutase, catalase, desferrioxamine, verapamil and disulfiram in experimental colitis | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF THE ROYAL COLLEGE OF SURGEONS OF EDINBURGH | |
dc.contributor.department | , , | |
dc.identifier.volume | 42 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 27 | |
dc.identifier.endpage | 30 | |
dc.contributor.firstauthorID | 118516 | |